Max Robotics — Global Service Robot Directory + US Certification

About

Dr. L. Richstone is a leading urologic oncologist whose research has fundamentally advanced the surgical management of bladder cancer, particularly through the refinement and validation of robot-assisted radical cystectomy. As a key contributor to the International Robotic Cystectomy Consortium, Dr. Richstone has helped establish the long-term oncologic efficacy of minimally invasive techniques, demonstrating that robotic approaches can achieve durable cancer control while reducing patient morbidity. Their landmark work on ten-year outcomes from this multi-institutional cohort provides critical evidence that robot-assisted cystectomy offers comparable oncologic results to open surgery, with the added benefits of decreased blood loss and faster recovery. This research has directly influenced clinical guidelines and surgical practice worldwide, reassuring surgeons and patients alike about the safety and effectiveness of robotic techniques for high-risk bladder cancer. While their most cited paper has garnered significant attention in the urologic community, Dr. Richstone's broader body of work continues to shape the evolution of robotic urologic surgery, cementing their reputation as a pioneer in evidence-based minimally invasive oncology.